Maria Felice Brizzi
Overview
Explore the profile of Maria Felice Brizzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
2510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pace E, Accardo G, Lupia T, Brizzi M, Corcione S, De Rosa F
Pathogens
. 2024 Oct;
13(10).
PMID: 39452703
Herpes zoster ophthalmicus results from the reactivation of the latent varicella zoster virus, affecting the first branch of the trigeminal nerve. In 20-70% of cases, Zoster Ophthalmicus can lead to...
2.
Spokeviciute B, Kholia S, Brizzi M
Pharmacol Res
. 2024 Aug;
208:107352.
PMID: 39147005
A cutting-edge approach in cell-based immunotherapy for combating resistant cancer involves genetically engineered chimeric antigen receptor T (CAR-T) lymphocytes. In recent years, these therapies have demonstrated effectiveness, leading to their...
3.
Ceccotti E, Chiabotto G, Cedrino M, Gambella A, Delsedime L, Ghigo A, et al.
Biomedicines
. 2024 Jul;
12(7).
PMID: 39062090
Fibrosis is a marker of chronic kidney disease (CKD) and consists of the accumulation of the extracellular matrix (ECM) components, causing the progressive deterioration of kidney function. Human liver stem...
4.
De Filippo O, DAscenzo F, Iannaccone M, Bertaina M, Leone A, Borzillo I, et al.
Cardiovasc Diabetol
. 2023 Nov;
22(1):324.
PMID: 38017541
Background And Aims: Bempedoic Acid (BA) is a novel Lipid-Lowering Therapy (LLT). We performed a systematic review and meta-analysis to assess the efficacy and safety of BA in patients with...
5.
Sarcinella A, Femmino S, Brizzi M
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958693
Non-healing wound- and tissue-injury are commonly experienced worldwide by the aging population. The persistence of disease commonly leads to tissue infection, resulting in severe clinical complications. In the last decade,...
6.
Granato G, Gesmundo I, Pedrolli F, Kasarla R, Begani L, Banfi D, et al.
Front Immunol
. 2023 Aug;
14:1231363.
PMID: 37649486
COVID-19 is characterized by an excessive inflammatory response and macrophage hyperactivation, leading, in severe cases, to alveolar epithelial injury and acute respiratory distress syndrome. Recent studies have reported that SARS-CoV-2...
7.
Koni M, Lopatina T, Grange C, Sarcinella A, Cedrino M, Bruno S, et al.
Pharmacol Res
. 2023 Jul;
195:106871.
PMID: 37506784
Circulating tumour-derived extracellular vesicles are supposed to contribute to the spreading of distant metastasis. In this study, we investigated the impact of circulating extracellular vesicles derived from tumour-endothelial cells (TEVs)...
8.
Lopatina T, Grange C, Cavallari C, Navarro-Tableros V, Lombardo G, Rosso A, et al.
Oncogenesis
. 2023 Jul;
12(1):38.
PMID: 37491339
No abstract available.
9.
Pari B, Gallucci M, Ghigo A, Brizzi M
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979949
The correlation between diabetes mellitus and infectious diseases is widely recognized. DM patients are characterized by the impaired function of the immune system. This translates into the occurrence of a...
10.
Gibello L, DAntico S, Salafia M, Senetta R, Pomatto M, Orlando G, et al.
Pharmacol Res
. 2023 Mar;
190:106718.
PMID: 36878306
Current therapeutic approaches for chronic venous ulcers (CVUs) still require evidence of effectiveness. Diverse sources of extracellular vesicles (EVs) have been proposed for tissue regeneration, however the lack of potency...